Joshua A Salomon,Theo Vos,Daniel R Hogan,Michael Gagnon,Mohsen Naghavi,Ali Mokdad,Nazma Begum,Razibuzzaman Shah,Muhammad Karyana,Soewarta Kosen,Mario Reyna Farje,Gilberto Moncada,Arup Dutta,Sunil Sazawal,Andrew Dyer,Jason Seiler,Victor Aboyans,Lesley Baker,Amanda Baxter,Emelia J Benjamin,Kavi Bhalla,Aref Bin Abdulhak,Fiona Blyth,Rupert Bourne,Tasanee Braithwaite,Peter Brooks,Traolach S Brugha,Claire Bryan-Hancock,Rachelle Buchbinder,Peter Burney,Bianca Calabria,Honglei Chen,Sumeet S Chugh,Rebecca Cooley,Michael H Criqui,Marita Cross,Kaustubh C Dabhadkar,Nabila Dahodwala,Adrian Davis,Louisa Degenhardt,Cesar Díaz-Torné,E Ray Dorsey,Tim Driscoll,Karen Edmond,Alexis Elbaz,Majid Ezzati,Valery Feigin,Cleusa P Ferri,Abraham D Flaxman,Louise Flood,Marlene Fransen,Kana Fuse,Belinda J Gabbe,Richard F Gillum,Juanita Haagsma,James E Harrison,Rasmus Havmoeller,Roderick J Hay,Abdullah Hel-Baqui,Hans W Hoek,Howard Hoffman,Emily Hogeland,Damian Hoy,Deborah Jarvis,Ganesan Karthikeyan,Lisa Marie Knowlton,Tim Lathlean,Janet L Leasher,Stephen S Lim,Steven E Lipshultz,Alan D Lopez,Rafael Lozano,Ronan Lyons,Reza Malekzadeh,Wagner Marcenes,Lyn March,David J Margolis,Neil McGill,John McGrath,George A Mensah,Ana-Claire Meyer,Catherine Michaud,Andrew Moran,Rintaro Mori,Michele E Murdoch,Luigi Naldi,Charles R Newton,Rosana Norman,Saad B Omer,Richard Osborne,Neil Pearce,Fernando Perez-Ruiz,Norberto Perico,Konrad Pesudovs,David Phillips,Farshad Pourmalek,Martin Prince,Jürgen T Rehm,Guiseppe Remuzzi,Kathryn Richardson,Robin Room,Sukanta Saha,Uchechukwu Sampson,Lidia Sanchez-Riera,Maria Segui-Gomez,Saeid Shahraz,Kenji Shibuya,David Singh,Karen Sliwa,Emma Smith,Isabelle Soerjomataram,Timothy Steiner,Wilma A Stolk,Lars Jacob Stovner,Christopher Sudfeld,Hugh R Taylor,Imad M Tleyjeh,Marieke J van der Werf,Wendy L Watson,David J Weatherall,Robert Weintraub,Marc G Weisskopf,Harvey Whiteford,James D Wilkinson,Anthony D Woolf,Zhi-Jie Zheng,Christopher J L Murray,Jost B Jonas

Abstract:Background: Measurement of the global burden of disease with disability-adjusted life-years (DALYs) requires disability weights that quantify health losses for all non-fatal consequences of disease and injury. There has been extensive debate about a range of conceptual and methodological issues concerning the definition and measurement of these weights. Our primary objective was a comprehensive re-estimation of disability weights for the Global Burden of Disease Study 2010 through a large-scale empirical investigation in which judgments about health losses associated with many causes of disease and injury were elicited from the general public in diverse communities through a new, standardised approach. Methods: We surveyed respondents in two ways: household surveys of adults aged 18 years or older (face-to-face interviews in Bangladesh, Indonesia, Peru, and Tanzania; telephone interviews in the USA) between Oct 28, 2009, and June 23, 2010; and an open-access web-based survey between July 26, 2010, and May 16, 2011. The surveys used paired comparison questions, in which respondents considered two hypothetical individuals with different, randomly selected health states and indicated which person they regarded as healthier. The web survey added questions about population health equivalence, which compared the overall health benefits of different life-saving or disease-prevention programmes. We analysed paired comparison responses with probit regression analysis on all 220 unique states in the study. We used results from the population health equivalence responses to anchor the results from the paired comparisons on the disability weight scale from 0 (implying no loss of health) to 1 (implying a health loss equivalent to death). Additionally, we compared new disability weights with those used in WHO's most recent update of the Global Burden of Disease Study for 2004. Findings: 13,902 individuals participated in household surveys and 16,328 in the web survey. Analysis of paired comparison responses indicated a high degree of consistency across surveys: correlations between individual survey results and results from analysis of the pooled dataset were 0·9 or higher in all surveys except in Bangladesh (r=0·75). Most of the 220 disability weights were located on the mild end of the severity scale, with 58 (26%) having weights below 0·05. Five (11%) states had weights below 0·01, such as mild anaemia, mild hearing or vision loss, and secondary infertility. The health states with the highest disability weights were acute schizophrenia (0·76) and severe multiple sclerosis (0·71). We identified a broad pattern of agreement between the old and new weights (r=0·70), particularly in the moderate-to-severe range. However, in the mild range below 0·2, many states had significantly lower weights in our study than previously. Interpretation: This study represents the most extensive empirical effort as yet to measure disability weights. By contrast with the popular hypothesis that disability assessments vary widely across samples with different cultural environments, we have reported strong evidence of highly consistent results. Funding: Bill & Melinda Gates Foundation.

Standardised reporting of burden of disease studies: the STROBOD statement

Global Burden of Disease 2000: Version 2 methods and results

A systematic review of the methodological considerations in burden of disease studies

Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010

The global burden of disease 2000 project: aims, methods and data sources

The burden of disease and mortality by condition: data, methods, and results for 2001

Burden of infectious disease studies in Europe and the United Kingdom: a review of methodological design choices

How do world and European standard populations impact burden of disease studies? A case study of disability-adjusted life years (DALYs) in Scotland

Burden of Disease Research—Application of the Index of Disability Adjusted of Life Year

Guidelines for Reporting Oral Epidemiologic Studies to Inform Burden Estimation (GROESBE)

The Burden of Disease due to COVID-19 (BoCO-19): A study protocol for a secondary analysis of surveillance data in Southern and Eastern Europe, and Central Asia

Burden of disease studies supporting policymaking in the European Union: a systematic review

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

The role of burden of disease assessment in tracking progress towards achieving WHO global air quality guidelines

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying …

Global, Regional, National, and Subnational Big Data to Inform Health Equity Research: Perspectives from the Global Burden of Disease Study 2017